OXIS

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Poland, United Kingdom, South Africa

Active ingredients

The drug OXIS contains one active pharmaceutical ingredient (API):

1 Formoterol fumarate dihydrate
UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

Read about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
OXIS Inhalation powder Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AC13 Formoterol R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8239P, 8240Q
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02143608, 02147003, 02159696, 02159710, 08510249, 08510261, 08859041, 08859058, 10090820, 10090837, 10249870, 10542305, 10730099, 10759068, 10828131
Country: EE Ravimiamet Identifier(s): 1034064, 1034075
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61666, 61667
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 115904, 396080, 458677, 582556
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 139439, 139441, 147057, 147065, 162193, 162195, 32439, 32453, 374439, 375752
Country: IE Health Products Regulatory Authority Identifier(s): 38946, 38989
Country: IT Agenzia del Farmaco Identifier(s): 033312024
Country: JP 医薬品医療機器総合機構 Identifier(s): 2259711G1024, 2259711G2020
Country: MT Medicines Authority Identifier(s): MA046/02201, MA046/02202
Country: NL Z-Index G-Standaard Identifier(s): 14070235, 14070243
Country: NL Z-Index G-Standaard, PRK Identifier(s): 66478, 66486
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7866
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100089600, 100213388
Country: ZA Health Products Regulatory Authority Identifier(s): 32/10.2.1/0168

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.